These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 7837790)

  • 1. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
    Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
    Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
    Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
    Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
    Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
    Sumantran VN; Brederlau A; Funa K
    Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the neural intermediate filament proteins peripherin and neurofilament-66/alpha-internexin in neuroblastoma.
    Foley J; Witte D; Chiu FC; Parysek LM
    Lab Invest; 1994 Aug; 71(2):193-9. PubMed ID: 8078299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
    Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
    Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of bcl-2 gene product in neuroblastoma.
    Ramani P; Lu QL
    J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
    Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
    Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stromal Schwann cell during maturation of peripheral neuroblastomas. Immunohistochemical observations with antibodies to the neuronal class III beta-tubulin isotype (beta III) and S-100 protein.
    Katsetos CD; Karkavelas G; Frankfurter A; Vlachos IN; Vogeley K; Schober R; Wechsler W; Urich H
    Clin Neuropathol; 1994; 13(4):171-80. PubMed ID: 7955661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic large cell neuroblastoma.
    Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
    Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant bcl-2 and bax protein expression related to chemotherapy response in neuroblastoma.
    Gallo G; Giarnieri E; Bosco S; Cappelli C; Alderisio M; Giovagnoli MR; Giordano A; Vecchione A
    Anticancer Res; 2003; 23(1B):777-84. PubMed ID: 12680183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
    Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
    Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
    Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
    Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.